+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Zonisamide"

From
From
From
Antiepileptic Drugs Market - Forecast (2022 - 2027) - Product Thumbnail Image

Antiepileptic Drugs Market - Forecast (2022 - 2027)

  • Report
  • January 2022
  • 137 Pages
  • Global
From
The Treatment of Epilepsy. 3rd Edition - Product Thumbnail Image

The Treatment of Epilepsy. 3rd Edition

  • Book
  • July 2009
  • 1116 Pages
  • 8 Results (Page 1 of 1)
Loading Indicator

Zonisamide is a sulfonamide anticonvulsant drug used to treat epilepsy and other seizure disorders. It is classified as a Central Nervous System (CNS) drug, and is used to reduce the frequency and severity of seizures. Zonisamide is also used to treat bipolar disorder, and is sometimes used as an adjunct to other medications for the treatment of depression. Zonisamide is generally well-tolerated, with few side effects. Common side effects include dizziness, drowsiness, and nausea. The zonisamide market is a small but growing segment of the CNS drug market. It is used to treat a variety of neurological conditions, and is gaining popularity due to its effectiveness and low side effect profile. Zonisamide is available in both generic and branded forms, and is sold in both oral and injectable forms. Some companies in the zonisamide market include Sun Pharmaceuticals, Teva Pharmaceuticals, Mylan Pharmaceuticals, and Dr. Reddy's Laboratories. Show Less Read more